# Liposomal Amphotericin in Disseminated Leishmaniasis

> **NCT02025491** · PHASE3 · COMPLETED · sponsor: **Hospital Universitário Professor Edgard Santos** · enrollment: 20 (actual)

## Conditions studied

- Disseminated Leishmaniasis

## Interventions

- **DRUG:** Liposomal Amphotericin B

## Key facts

- **NCT ID:** NCT02025491
- **Lead sponsor:** Hospital Universitário Professor Edgard Santos
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2013-02
- **Final completion:** 2013-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-01-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02025491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02025491, "Liposomal Amphotericin in Disseminated Leishmaniasis". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT02025491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*